Identification of direct modulators of transcription factor proteinprotein interactions is a key challenge for ligand discovery that promises to significantly advance current understanding of,and approaches to,cancer therapy.We have utilized a genetically encoded high-throughput screening platform for the identification of protein-protein interaction inhibitors.